Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic and Subjective Effects of Terpenes Administered Alone and in Combination With THC
NCT04451863Phase 1Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Dec 2021
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of myrcene, beta-caryophyllene and dronabinol in pain (15 arms), sponsored by University of California, Los Angeles. Primary endpoints: Analgesia as measured using the Cold Pressor Test at 7 hours and Subject-rated drug effects of abuse liability at 7 hours. Started Dec 2021; status: active, not recruiting.
02
Drugs
myrcenebeta-caryophyllenedronabinol
03
Conditions
pain
Beyond the preview
Go deeper on NCT04451863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451863.